Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial

Abstract Background Colistin-carbapenem combination therapy is frequently used for carbapenem-resistant Gram-negative infections, but its impact on subsequent acquisition of carbapenem-resistant Enterobacterales (CRE) requires further investigation. We evaluated the incidence of CRE acquisition and...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Amir Nutman, Elizabeth Temkin, Jonathan Lellouche, Maayan Amar Ben Dalak, Ella Kaplan, Mor Lurie-Weinberger, Yael Dishon Benattar, Ami Neuberger, Anat Stern, Vered Daitch, Noa Eliakim-Raz, Emanuele Durante-Mangoni, Mariano Bernardo, Domenico Iossa, George Daikos, Anna Skiada, Ioannis Pavleas, Lena Friberg, Ursula Theuretzbacher, Leonard Leibovici, Mical Paul, Yehuda Carmeli, AIDA Study Group
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2025-11-01
Seri Bilgileri:	Antimicrobial Resistance and Infection Control
Konular:	Colistin Meropenem Combination treatment Infection Colonization Carbapenem-resistant Enterobacterales (CRE)
Online Erişim:	https://doi.org/10.1186/s13756-025-01651-1
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!